Logo image of AIL.DE

AIR LIQUIDE SA (AIL.DE) Stock Fundamental Analysis

FRA:AIL - Deutsche Boerse Ag - FR0000120073 - Common Stock - Currency: EUR

175.12  -1.42 (-0.8%)

Fundamental Rating

5

Overall AIL gets a fundamental rating of 5 out of 10. We evaluated AIL against 67 industry peers in the Chemicals industry. AIL has an excellent profitability rating, but there are some minor concerns on its financial health. While showing a medium growth rate, AIL is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

AIL had positive earnings in the past year.
AIL had a positive operating cash flow in the past year.
In the past 5 years AIL has always been profitable.
Each year in the past 5 years AIL had a positive operating cash flow.
AIL.DE Yearly Net Income VS EBIT VS OCF VS FCFAIL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

1.2 Ratios

AIL has a Return On Assets of 6.37%. This is in the better half of the industry: AIL outperforms 78.26% of its industry peers.
The Return On Equity of AIL (12.31%) is better than 76.81% of its industry peers.
The Return On Invested Capital of AIL (9.63%) is better than 86.96% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AIL is above the industry average of 6.29%.
The last Return On Invested Capital (9.63%) for AIL is above the 3 year average (9.47%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.37%
ROE 12.31%
ROIC 9.63%
ROA(3y)6.1%
ROA(5y)5.92%
ROE(3y)12.2%
ROE(5y)12.34%
ROIC(3y)9.47%
ROIC(5y)8.98%
AIL.DE Yearly ROA, ROE, ROICAIL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

1.3 Margins

Looking at the Profit Margin, with a value of 12.22%, AIL belongs to the top of the industry, outperforming 88.41% of the companies in the same industry.
In the last couple of years the Profit Margin of AIL has grown nicely.
The Operating Margin of AIL (19.93%) is better than 92.75% of its industry peers.
In the last couple of years the Operating Margin of AIL has grown nicely.
Looking at the Gross Margin, with a value of 63.01%, AIL belongs to the top of the industry, outperforming 92.75% of the companies in the same industry.
In the last couple of years the Gross Margin of AIL has remained more or less at the same level.
Industry RankSector Rank
OM 19.93%
PM (TTM) 12.22%
GM 63.01%
OM growth 3Y3.78%
OM growth 5Y2.86%
PM growth 3Y3.49%
PM growth 5Y3.63%
GM growth 3Y1.78%
GM growth 5Y0.07%
AIL.DE Yearly Profit, Operating, Gross MarginsAIL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AIL is creating some value.
AIL has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, AIL has more shares outstanding
AIL has a better debt/assets ratio than last year.
AIL.DE Yearly Shares OutstandingAIL.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
AIL.DE Yearly Total Debt VS Total AssetsAIL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

AIL has an Altman-Z score of 3.86. This indicates that AIL is financially healthy and has little risk of bankruptcy at the moment.
AIL's Altman-Z score of 3.86 is fine compared to the rest of the industry. AIL outperforms 78.26% of its industry peers.
The Debt to FCF ratio of AIL is 4.43, which is a neutral value as it means it would take AIL, 4.43 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.43, AIL is in the better half of the industry, outperforming 79.71% of the companies in the same industry.
A Debt/Equity ratio of 0.37 indicates that AIL is not too dependend on debt financing.
The Debt to Equity ratio of AIL (0.37) is better than 62.32% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 4.43
Altman-Z 3.86
ROIC/WACC1.33
WACC7.23%
AIL.DE Yearly LT Debt VS Equity VS FCFAIL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.3 Liquidity

AIL has a Current Ratio of 0.88. This is a bad value and indicates that AIL is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.88, AIL is not doing good in the industry: 88.41% of the companies in the same industry are doing better.
AIL has a Quick Ratio of 0.88. This is a bad value and indicates that AIL is not financially healthy enough and could expect problems in meeting its short term obligations.
AIL has a worse Quick ratio (0.65) than 86.96% of its industry peers.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.65
AIL.DE Yearly Current Assets VS Current LiabilitesAIL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 19.88% over the past year.
The Earnings Per Share has been growing by 11.55% on average over the past years. This is quite good.
AIL shows a decrease in Revenue. In the last year, the revenue decreased by -1.99%.
The Revenue has been growing slightly by 4.30% on average over the past years.
EPS 1Y (TTM)19.88%
EPS 3Y12.6%
EPS 5Y11.55%
EPS Q2Q%33.27%
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y5.06%
Revenue growth 5Y4.3%
Sales Q2Q%0.38%

3.2 Future

Based on estimates for the next years, AIL will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.15% on average per year.
Based on estimates for the next years, AIL will show a small growth in Revenue. The Revenue will grow by 4.06% on average per year.
EPS Next Y9.9%
EPS Next 2Y10.48%
EPS Next 3Y10.45%
EPS Next 5Y10.15%
Revenue Next Year3.69%
Revenue Next 2Y3.9%
Revenue Next 3Y4.39%
Revenue Next 5Y4.06%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
AIL.DE Yearly Revenue VS EstimatesAIL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B
AIL.DE Yearly EPS VS EstimatesAIL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 27.23, which means the current valuation is very expensive for AIL.
The rest of the industry has a similar Price/Earnings ratio as AIL.
AIL's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.41.
The Price/Forward Earnings ratio is 24.78, which indicates a rather expensive current valuation of AIL.
AIL's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 35.19. AIL is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 27.23
Fwd PE 24.78
AIL.DE Price Earnings VS Forward Price EarningsAIL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as AIL.
AIL's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 36.22
EV/EBITDA 14.11
AIL.DE Per share dataAIL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of AIL may justify a higher PE ratio.
PEG (NY)2.75
PEG (5Y)2.36
EPS Next 2Y10.48%
EPS Next 3Y10.45%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.87%, AIL has a reasonable but not impressive dividend return.
AIL's Dividend Yield is comparable with the industry average which is at 2.99.
AIL's Dividend Yield is slightly below the S&P500 average, which is at 2.35.
Industry RankSector Rank
Dividend Yield 1.87%

5.2 History

The dividend of AIL has a limited annual growth rate of 5.86%.
Dividend Growth(5Y)5.86%
Div Incr Years6
Div Non Decr Years6
AIL.DE Yearly Dividends per shareAIL.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

51.97% of the earnings are spent on dividend by AIL. This is a bit on the high side, but may be sustainable.
AIL's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP51.97%
EPS Next 2Y10.48%
EPS Next 3Y10.45%
AIL.DE Yearly Income VS Free CF VS DividendAIL.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
AIL.DE Dividend Payout.AIL.DE Dividend Payout, showing the Payout Ratio.AIL.DE Dividend Payout.PayoutRetained Earnings

AIR LIQUIDE SA

FRA:AIL (7/11/2025, 7:00:00 PM)

175.12

-1.42 (-0.8%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)04-22 2025-04-22
Earnings (Next)07-29 2025-07-29
Inst Owners27.27%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap101.30B
Analysts78.75
Price Target198.82 (13.53%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.87%
Yearly Dividend2.98
Dividend Growth(5Y)5.86%
DP51.97%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.13%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.25%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.72%
Valuation
Industry RankSector Rank
PE 27.23
Fwd PE 24.78
P/S 3.74
P/FCF 36.22
P/OCF 16.02
P/B 3.77
P/tB 9.94
EV/EBITDA 14.11
EPS(TTM)6.43
EY3.67%
EPS(NY)7.07
Fwd EY4.04%
FCF(TTM)4.84
FCFY2.76%
OCF(TTM)10.93
OCFY6.24%
SpS46.77
BVpS46.43
TBVpS17.62
PEG (NY)2.75
PEG (5Y)2.36
Profitability
Industry RankSector Rank
ROA 6.37%
ROE 12.31%
ROCE 12.72%
ROIC 9.63%
ROICexc 10.08%
ROICexgc 17.03%
OM 19.93%
PM (TTM) 12.22%
GM 63.01%
FCFM 10.34%
ROA(3y)6.1%
ROA(5y)5.92%
ROE(3y)12.2%
ROE(5y)12.34%
ROIC(3y)9.47%
ROIC(5y)8.98%
ROICexc(3y)9.91%
ROICexc(5y)9.43%
ROICexgc(3y)16.92%
ROICexgc(5y)16.28%
ROCE(3y)12.5%
ROCE(5y)11.85%
ROICexcg growth 3Y3.94%
ROICexcg growth 5Y3.85%
ROICexc growth 3Y4.91%
ROICexc growth 5Y4.63%
OM growth 3Y3.78%
OM growth 5Y2.86%
PM growth 3Y3.49%
PM growth 5Y3.63%
GM growth 3Y1.78%
GM growth 5Y0.07%
F-Score8
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 4.43
Debt/EBITDA 1.25
Cap/Depr 140.72%
Cap/Sales 13.03%
Interest Coverage 20.46
Cash Conversion 80.06%
Profit Quality 84.6%
Current Ratio 0.88
Quick Ratio 0.65
Altman-Z 3.86
F-Score8
WACC7.23%
ROIC/WACC1.33
Cap/Depr(3y)136.72%
Cap/Depr(5y)133.49%
Cap/Sales(3y)12.08%
Cap/Sales(5y)12.32%
Profit Quality(3y)89.93%
Profit Quality(5y)95.75%
High Growth Momentum
Growth
EPS 1Y (TTM)19.88%
EPS 3Y12.6%
EPS 5Y11.55%
EPS Q2Q%33.27%
EPS Next Y9.9%
EPS Next 2Y10.48%
EPS Next 3Y10.45%
EPS Next 5Y10.15%
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y5.06%
Revenue growth 5Y4.3%
Sales Q2Q%0.38%
Revenue Next Year3.69%
Revenue Next 2Y3.9%
Revenue Next 3Y4.39%
Revenue Next 5Y4.06%
EBIT growth 1Y6.38%
EBIT growth 3Y9.02%
EBIT growth 5Y7.28%
EBIT Next Year58.93%
EBIT Next 3Y22.7%
EBIT Next 5Y15.83%
FCF growth 1Y-2.53%
FCF growth 3Y1.77%
FCF growth 5Y6.15%
OCF growth 1Y0.95%
OCF growth 3Y4.31%
OCF growth 5Y6.05%